These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 8937280)

  • 41. Trypanosoma cruzi: Immunological predictors of benznidazole efficacy during experimental infection.
    Fernández MC; González Cappa SM; Solana ME
    Exp Parasitol; 2010 Feb; 124(2):172-80. PubMed ID: 19747482
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Experimental benznidazole treatment of Trypanosoma cruzi II strains isolated from children of the Jequitinhonha Valley, Minas Gerais, Brazil, with Chagas disease.
    Oliveira-Silva JC; Machado-de-Assis GF; Oliveira MT; Paiva NC; Araújo MS; Carneiro CM; Martins-Filho OA; Martins HR; Lana Md
    Mem Inst Oswaldo Cruz; 2015 Feb; 110(1):86-94. PubMed ID: 25742267
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of the ELISA-F29 test as an early marker of therapeutic efficacy in adults with chronic Chagas disease.
    Fabbro D; Velazquez E; Bizai ML; Denner S; Olivera V; Arias E; Pravia C; Ruiz AM
    Rev Inst Med Trop Sao Paulo; 2013; 55(3):. PubMed ID: 23740013
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Experimental treatment of chronic Trypanosoma cruzi infection in mice with 2-n-propylquinoline.
    Nakayama H; Ferreira ME; Rojas de Arias A; Vera de Bilbao N; Torres S; Schinini A; Fournet A
    Phytother Res; 2001 Nov; 15(7):630-2. PubMed ID: 11746849
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment with benznidazole in association with immunosuppressive drugs in mice chronically infected with Trypanosoma cruzi: investigation into the possible development of neoplasias.
    Andrade SG; Mesquita IM; Jambeiro JF; Santos IF; Portella RS
    Rev Soc Bras Med Trop; 2003; 36(4):441-7. PubMed ID: 12937719
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An update on benznidazole for the treatment of patients with Chagas disease.
    Thakare R; Dasgupta A; Chopra S
    Drugs Today (Barc); 2018 Jan; 54(1):15-23. PubMed ID: 29569658
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Trypomastigote Small Surface Antigen from Trypanosoma cruzi Improves Treatment Evaluation and Diagnosis in Pediatric Chagas Disease.
    Balouz V; Melli LJ; Volcovich R; Moscatelli G; Moroni S; González N; Ballering G; Bisio M; Ciocchini AE; Buscaglia CA; Altcheh J
    J Clin Microbiol; 2017 Dec; 55(12):3444-3453. PubMed ID: 28978686
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vivo susceptibility to benznidazole of Trypanosoma cruzi strains from the western Brazilian Amazon.
    Teston AP; Monteiro WM; Reis D; Bossolani GD; Gomes ML; de Araújo SM; Bahia MT; Barbosa MG; Toledo MJ
    Trop Med Int Health; 2013 Jan; 18(1):85-95. PubMed ID: 23130989
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sequential combined treatment with allopurinol and benznidazole in the chronic phase of Trypanosoma cruzi infection: a pilot study.
    Perez-Mazliah DE; Alvarez MG; Cooley G; Lococo BE; Bertocchi G; Petti M; Albareda MC; Armenti AH; Tarleton RL; Laucella SA; Viotti R
    J Antimicrob Chemother; 2013 Feb; 68(2):424-37. PubMed ID: 23104493
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Use of an enzyme-linked immunosorbent assay that utilizes the Tc13Tul antigen of Trypanosoma cruzi to monitor patients after treatment with benznidazole.
    Santamaría AL; De Rissio AM; Riarte A; Garavaglia PA; Bruballa AC; Rodríguez MA; Irazu LE; Ruiz AM; García GA
    Diagn Microbiol Infect Dis; 2013 Jun; 76(2):197-205. PubMed ID: 23537784
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of chronic Chagas' disease with benznidazole: clinical and serologic evolution of patients with long-term follow-up.
    Viotti R; Vigliano C; Armenti H; Segura E
    Am Heart J; 1994 Jan; 127(1):151-62. PubMed ID: 8273735
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anti-parasitic effect of vitamin C alone and in combination with benznidazole against Trypanosoma cruzi.
    Puente V; Demaria A; Frank FM; Batlle A; Lombardo ME
    PLoS Negl Trop Dis; 2018 Sep; 12(9):e0006764. PubMed ID: 30240395
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Trypanocidal drugs for chronic asymptomatic Trypanosoma cruzi infection.
    Villar JC; Marin-Neto JA; Ebrahim S; Yusuf S
    Cochrane Database Syst Rev; 2002; (1):CD003463. PubMed ID: 11869663
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment Success in Trypanosoma cruzi Infection Is Predicted by Early Changes in Serially Monitored Parasite-Specific T and B Cell Responses.
    Alvarez MG; Bertocchi GL; Cooley G; Albareda MC; Viotti R; Perez-Mazliah DE; Lococo B; Castro Eiro M; Laucella SA; Tarleton RL
    PLoS Negl Trop Dis; 2016 Apr; 10(4):e0004657. PubMed ID: 27128444
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serological based monitoring of a cohort of patients with chronic Chagas disease treated with benznidazole in a highly endemic area of northern Argentina.
    Niborski LL; Grippo V; Lafón SO; Levitus G; García-Bournissen F; Ramirez JC; Burgos JM; Bisio M; Juiz NA; Ayala V; Coppede M; Herrera V; López C; Contreras A; Gómez KA; Elean JC; Mujica HD; Schijman AG; Levin MJ; Longhi SA
    Mem Inst Oswaldo Cruz; 2016 May; 111(6):365-71. PubMed ID: 27223650
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Summaries for patients. Long-term outcomes of treating nonacute Chagas disease with benznidazole.
    Ann Intern Med; 2006 May; 144(10):I32. PubMed ID: 16702585
    [No Abstract]   [Full Text] [Related]  

  • 57. Uneventful benznidazole treatment of acute Chagas disease during pregnancy: a case report.
    Corrêa VR; Barbosa FG; Melo Junior CA; D'Albuquerque e Castro LF; Andrade Junior HF; Nascimento N
    Rev Soc Bras Med Trop; 2014; 47(3):397-400. PubMed ID: 25075496
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Benznidazole/Poloxamer 407 Solid Dispersion as a New Strategy to Improve the Treatment of Experimental Trypanosoma cruzi Infection.
    Davies C; Simonazzi A; Micheloud JF; Ragone PG; Cid AG; Negrette OS; Bermúdez JM; Parada LA
    J Parasitol; 2020 Jun; 106(3):323-333. PubMed ID: 32369594
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of the toxicity of two treatment schemes with benznidazole for chronic Chagas disease: a prospective cohort study in two Spanish referral centres.
    Crespillo-Andújar C; López-Vélez R; Trigo E; Norman F; Díaz-Menéndez M; Monge-Maillo B; Arsuaga M; Pérez-Molina JA
    Clin Microbiol Infect; 2020 Mar; 26(3):384.e1-384.e4. PubMed ID: 31740423
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Experimental combination therapy using low doses of benznidazole and allopurinol in mouse models of Trypanosoma cruzi chronic infection.
    Rial MS; Scalise ML; López Alarcón M; Esteva MI; Búa J; Benatar AF; Prado NG; Riarte AR; Fichera LE
    Parasitology; 2019 Mar; 146(3):305-313. PubMed ID: 30301480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.